We are pleased to announce that SpiroChem will be participating in Discovery on Target (DoT) 2025,, taking place in Boston, Massachusetts, from September 22 - 25, 2025.
Renowned as one of the leading drug discovery conferences, DoT brings together global experts to explore the latest innovations in therapeutic targets and technologies. The program will cover emerging approaches across modalities, from degraders and molecular glues to novel drug design strategies.
Meet our team on-site:
Thomas Fessard, PhD – Chief Executive Officer – Business Development Manager
Gerhard Müller, PhD – Chief Scientific Officer – Business Development Manager
In addition to our participation, Gerhard Müller, PhD, Chief Scientific Officer at SpiroChem, will deliver a talk as part of the Degraders & Molecular Glues – Part 1 session:
🎤 “Relevance of linker-selection and -chemistry in the design of efficacious PROTACs – a CRO perspective”
📅 Wednesday, September 24, 2025 – 9:45 AM
We look forward to connecting with the Boston community and sharing how SpiroChem supports innovation throughout the drug discovery value chain.
